Cartesian Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Cartesian Therapeutics, Inc. (RNAC) reported Increase (Decrease) in Deferred Revenue of -$88.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-08
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$88.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $2.50M, a 74.57% decline year-over-year.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $24.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2017 was $2.43M, a 76.64% decline from fiscal 2016.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2016 was $10.41M.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$507.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$20.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$88.00K 10-Q · filed 2018-08-08 | $2.41M derived: sum of 3 quarters · filed 2018-08-08 | $2.43M derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $2.50M derived: sum of 2 quarters · filed 2018-05-09 | $2.52M derived: sum of 3 quarters · filed 2018-05-09 | $2.38M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.52M derived: sum of 2 quarters · filed 2018-03-15 | $2.38M derived: sum of 3 quarters · filed 2018-08-08 | $2.43M 10-K · filed 2018-03-15 |
| 2017-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$123.00K derived: sum of 2 quarters · filed 2018-08-08 | -$66.00K 10-Q · filed 2017-11-07 | $9.76M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-06-30 | -$147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$90.00K 10-Q · filed 2018-08-08 | $9.73M derived: sum of 3 quarters · filed 2018-08-08 | $9.39M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $57.00K 10-Q · filed 2018-05-09 | $9.88M derived: sum of 2 quarters · filed 2018-05-09 | $9.53M derived: sum of 3 quarters · filed 2018-05-09 | $10.08M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $9.48M derived: sum of 2 quarters · filed 2018-03-15 | $10.02M derived: sum of 3 quarters · filed 2018-03-15 | $10.41M 10-K · filed 2018-03-15 |
| 2016-09-30 | -$347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $200.00K derived: sum of 2 quarters · filed 2017-11-07 | $586.00K 10-Q · filed 2017-11-07 | $113.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $547.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $933.00K 10-Q · filed 2017-08-11 | $460.00K derived: sum of 3 quarters · filed 2018-03-15 | -$347.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $386.00K 10-Q · filed 2017-05-11 | -$87.00K derived: sum of 2 quarters · filed 2018-03-15 | -$894.00K derived: sum of 3 quarters · filed 2018-03-15 | |
| 2015-12-31 | -$473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.28M derived: sum of 2 quarters · filed 2018-03-15 | -$507.00K 10-K · filed 2018-03-15 | |
| 2015-09-30 | -$807.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$34.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $773.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | -$20.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |